Apollomics, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Pleasanton CA United States (2016)

Organization Overview

First Clinical Trial
2017
NCT03053466
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Apollomics Inc. | CBT Pharmaceuticals (Australia) Pty Ltd | CBT Pharmaceuticals, Inc. | EVP and Chief Operating Officer, CBT Pharmaceuticals, Inc.